Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Knockout model reveals role of fibronectin extra domain A sepsis outcomes

June 13, 2016

FDA grants fast track designation to Remedy's Cirara

June 9, 2016

Enanta Pharmaceuticals patents FXR agonists

June 9, 2016

Novartis initiates phase II trial of CLR-325 in chronic stable heart failure

June 9, 2016

FDA approves Allergan's FDC Byvalson for hypertension

June 7, 2016

Terumo launches HeartSheet in Japan

June 7, 2016

High endostatin levels may provide protective effect against cardiovascular events

June 7, 2016

IL-27p28 gene polymorphisms may be correlated with insulin resistance and artery disease

June 6, 2016

sDPP-IV levels associated with all-cause death in patients with PAD

June 6, 2016

Merck & Co. discloses sGC activators

June 3, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...